Janssen reveals data from erdafitinib study

Erdafitinib boosted survival in patients with certain conditions including metastatic urothelial carcinoma - News - PharmaTimes

Related Keywords

Paris ,France General ,France ,Saclay ,Janssen Cilag Gmb ,Yohann Loriot ,Martin Vogel ,University Of Paris ,Janssen Pharmaceutical Companies Of Johnson ,Janssen Pharmaceutical Companies ,Janssen Cilag Gmbh ,Janssen ,Erdafitinib ,Research ,